Title: ?Control of DNA Topology? PI: Yuk-Ching Tse-Dinh, PhD Project Summary/Abstract The long term goals of this project are to understand how the activity, regulation and interactions of DNA topoisomerases control DNA topology and affect vital cellular functions. Drugs that target type IB and type IIA topoisomerases are used in current anti-cancer and anti-bacterial therapy. Bacterial type IA topoisomerases have been validated as a useful target for discovery and development of novel antibacterial therapy to treat drug resistant bacterial pathogens that cannot be eliminated with current antibiotics, including the antibiotics that target bacterial topoisomerase II. The proposed research activities for the next funding period would elucidate the complete catalytic mechanism and provide new insights into the protein-protein interactions and regulation of Escherichia coli topoisomerase I activity. This information is needed to fully realize the potential of discovery of novel antibacterial drugs specific for type IA topoisomerases that is present in every bacterial pathogen as a potential therapeutic target. Topoisomerase I catalyzes the relaxation of negatively supercoiled DNA by cleaving a single DNA strand in the underwound duplex DNA and passing the complementary DNA single strand through the break before religation of the cleaved strand to increase the DNA winding. The molecular mechanism of the large enzyme conformational changes that are required for the coordinated movement of the passing DNA is the critical barrier for elucidating how bacterial topoisomerase I can relax negatively supercoiled DNA with high efficiency to prevent hypernegative DNA supercoiling and R-loop stabilization that can arise during transcription elongation. Structural and biochemical studies will be conducted to test hypotheses generated from crystal structures obtained in this project on the mechanism of enzyme DNA conformational change and DNA passage. Interaction sites of endogenous bacterial toxins that can act as inhibitors of topoisomerase I catalytic activity will be identified. Our preliminary results showed that deacetylation of topoisomerase I may be an important function of the E. coli deacetylase CobB. Novel mechanisms of regulation of DNA topology and bacteria growth via acetylation-deacetylation of topoisomerase I will be investigated. The project will include direct participations of co-Investigators who are experts in structural biology and single molecule studies of enzyme-DNA interactions. The results will provide the molecular basis of bacterial topoisomerase I function, and new insights into growth regulation of bacteria via modulation of topoisomerase I enzyme activity. Success in these experiments would support the drug discovery efforts of utilizing bacterial topoisomerase I as a new target for antibiotics.

Public Health Relevance

Title: ?Control of DNA Topology? PI: Yuk-Ching Tse-Dinh, PhD Project Narrative This highly innovative project is focused on understanding the structure, mechanism, interactions and regulation of bacterial topoisomerase I, a validated target for discovery of novel antibacterial compounds. The proposed work is of timely relevance for the development of new antibacterial therapy to combat the global health problem of multi- drug resistant bacterial pathogens.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM054226-20
Application #
9976333
Study Section
Prokaryotic Cell and Molecular Biology Study Section (PCMB)
Program Officer
Reddy, Michael K
Project Start
1996-04-01
Project End
2021-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
20
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Florida International University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
071298814
City
Miami
State
FL
Country
United States
Zip Code
33199
Zhou, Qingxuan; Gomez Hernandez, Mario E; Fernandez-Lima, Francisco et al. (2018) Biochemical Basis of E. coli Topoisomerase I Relaxation Activity Reduction by Nonenzymatic Lysine Acetylation. Int J Mol Sci 19:
Banda, Srikanth; Cao, Nan; Tse-Dinh, Yuk-Ching (2017) Distinct Mechanism Evolved for Mycobacterial RNA Polymerase and Topoisomerase I Protein-Protein Interaction. J Mol Biol 429:2931-2942
Zhou, Qingxuan; Zhou, Yan Ning; Jin, Ding Jun et al. (2017) Deacetylation of topoisomerase I is an important physiological function of E. coli CobB. Nucleic Acids Res 45:5349-5358
Cheng, Bokun; Zhou, Qingxuan; Weng, Liwei et al. (2017) Identification of proximal sites for unwound DNA substrate in Escherichia coli topoisomerase I with oxidative crosslinking. FEBS Lett 591:28-38
Tan, Kemin; Cao, Nan; Cheng, Bokun et al. (2016) Insights from the Structure of Mycobacterium tuberculosis Topoisomerase I with a Novel Protein Fold. J Mol Biol 428:182-193
Tiwari, Purushottam B; Chapagain, Prem P; Banda, Srikanth et al. (2016) Characterization of molecular interactions between Escherichia coli RNA polymerase and topoisomerase I by molecular simulations. FEBS Lett 590:2844-51
Banda, Srikanth; Tiwari, Purushottam Babu; Darici, Yesim et al. (2016) Investigating direct interaction between Escherichia coli topoisomerase I and RecA. Gene 585:65-70
Tan, Kemin; Zhou, Qingxuan; Cheng, Bokun et al. (2015) Structural basis for suppression of hypernegative DNA supercoiling by E. coli topoisomerase I. Nucleic Acids Res 43:11031-46
Cheng, Bokun; Annamalai, Thirunavukkarasu; Sandhaus, Shayna et al. (2015) Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II). PLoS One 10:e0120022
Tse-Dinh, Yuk-Ching (2015) Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics. Future Med Chem 7:459-71

Showing the most recent 10 out of 28 publications